Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: post hoc analysis of three randomised controlled trials
Armstrong MJ, Okanoue T, Sundby Palle M, et al.
Diabetes Obes Metab. Pub. online 28 Nov 2024.
Leggi


